Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial (Q34246898)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

Christopher B. Granger

1

object named as

Christopher B Granger

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9

object named as

Karl Swedberg

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

3

object named as

Salim Yusuf

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2

object named as

John J V McMurray

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

8

object named as

Marc A Pfeffer

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

CHARM Investigators and Committees

10

object named as

CHARM Investigators and Committees

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Eric L Michelson

5

object named as

Eric L Michelson

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

4

object named as

Peter Held

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Bertil Olofsson

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jan Ostergren

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

362

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9386

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

772-776

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) pro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Are Patients Who Develop Angioedema With ACE Inhibition at Risk of the Same Problem With AT1 Receptor Blockers?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914284-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(03)14284-5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34246898&oldid=1744703952"